![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Oncol. , 11 June 2024
Sec. Head and Neck Cancer
Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1436609
This article is a correction to:
LncRNA FOXD3-AS1 Promotes the Malignant Progression of Nasopharyngeal Carcinoma Through Enhancing the Transcription of YBX1 by H3K27Ac Modification
By Yang H, Pan Y, Zhang J, Jin L and Zhang X (2021). Front. Oncol. 11:715635. doi: 10.3389/fonc.2021.715635
In the published article, there was an error in Figure 5 due to incorrect image editing in Figure 5D as published. The corrected Figure 5 appear below.
Figure 5 YBX1 reversed the proliferation, migration and invasion induced by knockdown of lncRNA FOXD3-AS1. (A) The expression of YBX1 was upregulated by transient transfection in cells silencing FOXD3-AS1 (shF-1), which was detected by western blot. (B, C) That YBX1 reversed the proliferation induced by knockdown of lncRNA FOXD3-AS1 was demonstrated by CCK8 assays (B) and colony forming assays (C) in HONE1 and SUNE1 cells. Colonies of colony forming assays were counted and compared by histogram (C, right). (D, E) That YBX1 reversed migration (D) and invasion (E) induced by knockdown of FOXD3-AS1 was validated by transwell assays in HONE1 and SUNE1 cells. Cells of transwell assays were calculated and compared by histograms [(D, E), right]. *P < 0.05, **P < 0.01.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: FOXD3-AS1, nasopharyngeal carcinoma, YBX1, H3K27ac, lnc RNA
Citation: Yang H, Pan Y, Zhang J, Jin L and Zhang X (2024) Corrigendum: LncRNA FOXD3-AS1 promotes the malignant progression of nasopharyngeal carcinoma through enhancing the transcription of YBX1 by H3K27Ac modification. Front. Oncol. 14:1436609. doi: 10.3389/fonc.2024.1436609
Received: 22 May 2024; Accepted: 03 June 2024;
Published: 11 June 2024.
Edited and Reviewed by:
Kwai Fung Hui, The University of Hong Kong, Hong Kong SAR, ChinaCopyright © 2024 Yang, Pan, Zhang, Jin and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xi Zhang, eHkzemhhbmd4aUBjc3UuZWR1LmNu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.